Programmable shunt valves, a standard treatment for normal pressure hydrocephalus, are susceptible to magnetic interference from MRI scans, a new systematic review and pooled analysis has found. The study, published in Fluids and Barriers of the CNS, aggregated data from 11 studies involving 475 patients to quantify how often these medical devices require reprogramming after exposure to magnetic fields. The researchers found that valve setting alterations were required in 44.2% of cases following exposure to 1.5 Tesla (1.5T) MRI and 55.2% of cases after 3 Tesla (3T) exposure. Although the 3T field showed a numerically higher incidence of changes, the difference between the two field strengths was not statistically significant, suggesting that magnetic field strength alone may not be the sole determinant of valve instability.
Normal pressure hydrocephalus is a neurological condition characterized by a triad of symptoms: gait disturbance, cognitive deterioration, and urinary incontinence, occurring in the context of normal cerebrospinal fluid pressure. The estimated pooled prevalence of the condition is 1.30%, though researchers note this figure is likely an underestimate due to frequent misdiagnosis with Parkinsonian disorders and concomitant dementia. Since the introduction of ventriculoperitoneal and lumbo-peritoneal shunts in 1956, surgical implantation has remained the gold standard treatment for managing the condition. These shunt systems divert excess cerebrospinal fluid from the cerebral ventricles to the intraperitoneal space, effectively reducing intracranial pressure and restoring physiological circulation.
The introduction of programmable shunt valves has improved the management of this condition by allowing for non-invasive modulation of cerebrospinal fluid drainage rates. Unlike conventional fixed-differential pressure valves, programmable valves use magnetically activated components to govern adjustable opening pressure settings. These settings dictate the precise threshold at which the valve permits fluid drainage, tailored to the specific individualized needs of each patient. While these devices have reduced the rates of overdrainage-related complications, such as non-traumatic subdural hematomas, they introduce a new vulnerability: susceptibility to external magnetic fields. There is growing evidence that magnetic interference during MRI scans can affect valve programmability and positioning, potentially worsening clinical outcomes if left unaddressed.
The systematic review was conducted in adherence to PRISMA 2020 guidelines and registered on PROSPERO. The research team performed an extensive literature search across PubMed and Embase databases from January 2000 to January 2025, aiming to identify studies evaluating the impact of MRI at 1.5T and 3T field strengths on valve settings. Only original, quantitative, peer-reviewed studies published in English that examined the longitudinal efficacy of MRI field strengths in adult populations were included. The eligibility criteria focused on studies analyzing magnetic field strengths for patients with NPH, with outcomes such as the percentage of valves affected and requiring reprogramming. Reviews, abstracts, editorials, and case reports were excluded to ensure the analysis relied on robust primary data.
From an initial screen of 3,321 studies, 3,251 were excluded based on titles and abstracts, leaving 70 full-text articles for assessment. Ultimately, 11 studies met the inclusion criteria and were included in the pooled analysis, encompassing a combined sample of 475 patients. The risk of bias for each included study was evaluated using the Risk of Bias in Non-randomized Studies of Exposures (ROBINS-E) tool. Four of the included studies were rated as having a serious or high overall risk of bias, primarily due to concerns regarding confounding, exposure classification, and outcome measurement. However, a sensitivity analysis excluding these high-risk studies did not meaningfully alter the pooled reprogramming rates or the conclusions of the head-to-head analysis, indicating that the primary findings are stable.
The primary outcome measured in the review was the assessment of valve settings following MRI exposure, specifically looking for changes in valve pressure settings. A valve setting alteration was defined as any measurable change in programmed opening pressure between pre-MRI and post-MRI assessment. The pooled analysis revealed that 44.2% of valves were affected at 1.5T, while 55.2% were affected at 3T. Statistical comparison using the Mann-Whitney U test yielded a p-value of 0.2514, revealing no significant difference between these field strengths. This finding suggests that while 3T MRI exposure results in a numerically higher rate of valve setting changes, it does not necessarily pose a significantly greater risk compared to 1.5T MRI in terms of the proportion of valves affected.
When analyzing specific valve types, the Codman Hakim valve exhibited the highest incidence of setting changes, with a rate of 37.05% at 3T. This was followed by the Sophysa Polaris valve at 18.46% and the Miethke proGAV 2 valve at 17.98%. However, statistical analysis using analysis of variance (ANOVA) revealed no significant difference in valve setting alteration rates across different valve types. This lack of statistical significance between manufacturers contrasts with the variability observed in individual studies, where some valve models showed high susceptibility while others demonstrated greater resistance. For instance, the Miethke proGAV 2 and Medtronic Strata MR showed high dysfunction rates in some reports, while other models like the Codman CERTAS Plus and Sophysa Polaris exhibited no dysfunction across multiple reports.
Random-effects meta-analysis provided pooled estimates of reprogramming rates, demonstrating a rate of 47% (95% CI: 1%, 97%) at 1.5T and 43% (95% CI: 4%, 89%) at 3T. These estimates were accompanied by high heterogeneity across studies, with I-squared values of 83.9% and 94.0% respectively. To directly compare field strengths, the researchers analyzed the only two studies that reported outcomes at both 1.5T and 3T within the same cohort using a paired random-effects risk ratio model. This analysis yielded a risk ratio of 1.29 (95% CI 0.77, 2.15), further indicating no statistically significant difference in reprogramming risk between 3T and 1.5T MRI. The high heterogeneity suggests that variability between studies, rather than magnetic field strength alone, may explain the differences in reported reprogramming rates.
The discussion highlights that the variability in reported outcomes may be attributed to study design heterogeneity, sample size discrepancies, differences in valve models, and variations in MRI exposure conditions. Differences in imaging protocols, such as sequence parameters, exposure durations, and spatial gradients of magnetic field intensity, likely contributed to inconsistencies in reprogramming rates. Additionally, the placement of programmable valves within the cranial cavity is an important factor influencing in vivo reprogramming susceptibility. The interaction of these devices with cerebrospinal fluid dynamics and adjacent brain structures may not be accurately replicated in ex vivo studies. Furthermore, valve-specific differences in magnetic shielding mechanisms impact susceptibility to MRI-induced changes, with certain models incorporating locking mechanisms that confer resistance to unintentional reprogramming.
The clinical implications of these findings are significant, as unintended changes in valve pressure settings may contribute to suboptimal cerebrospinal fluid drainage, potentially leading to clinical deterioration in vulnerable patients. Although alterations are typically reversible and reprogramming can be performed post-MRI, the risk of spontaneous valve resets necessitates caution. The study advocates for routine post-MRI valve setting evaluations to prevent adverse outcomes and ensure appropriate cerebrospinal fluid dynamics are maintained. Certain groups may warrant higher-priority post-MRI valve verification, including patients with Codman Hakim valves, which demonstrated the highest reprogramming rates, and those with recently implanted valves who may be more vulnerable to unintended setting shifts.
Limitations of the study include variability in study protocols, MRI exposure parameters, and timepoints for valve assessment. Many studies did not account for prior MRI exposure history or background magnetic field influences, introducing potential confounders. Heterogeneity in how studies defined a valve setting alteration, ranging from any measurable pressure change to only threshold-based shifts, likely contributed to inter-study variability. The small number of studies exclusively reporting 1.5T MRI exposure limits direct comparison between field strengths, and the lack of data on higher field strengths, such as 7T MRI, prevents broader conclusions on the impact of ultra-high-field imaging. Additionally, differences in shunt valve positioning and patient head orientation within the scanner may further influence reprogramming susceptibility.
In conclusion, programmable shunt valves remain susceptible to MRI-induced setting changes, though the difference between 1.5T and 3T MRI exposure is not statistically significant. While certain valve models demonstrate greater resistance to magnetic interference, routine post-MRI valve setting verification remains essential to prevent unintended pressure alterations. The variability in reprogramming rates across studies suggests that differences in imaging protocols, valve designs, and patient factors may all contribute to magnetic susceptibility. Further research, particularly involving in vivo studies, is necessary to refine MRI safety protocols, improve clinical outcomes for patients with hydrocephalus managed with programmable shunts, and establish evidence-based guidelines for pre- and post-imaging valve management.
Subject of Research: The effect of magnetic interference by magnetic resonance imaging on programmable shunt valves in patients with normal pressure hydrocephalus: a systematic review and pooled analysis
Article Title: The effect of magnetic interference by magnetic resonance imaging on programmable shunt valves in patients with normal pressure hydrocephalus: a systematic review and pooled analysis
Article References: Rathod, V., Kalasauskas, D., Ringel, F., Bola, H., Ramsay, D. S. C., Chhatwal, K., Namireddy, S. R., Kanakala, S., Ali, I., Nanoo, D., Gangwani, E., Gill, T., Jha, A., Salih, A., Varadpande, M., Kamath, A. G., Thavarajasingam, A., Jankovic, D., Kramer, A., & Thavarajasingam, S. G. (2026). The effect of magnetic interference by magnetic resonance imaging on programmable shunt valves in patients with normal pressure hydrocephalus: a systematic review and pooled analysis. Fluids and Barriers of the CNS, 23(1), Article 99. https://doi.org/10.1186/s12987-026-00837-y
Image Credits: AI Generated
DOI: 10.1186/s12987-026-00837-y
Keywords: effect, magnetic, interference, resonance, imaging, programmable, shunt, valves, patients, normal, pressure, hydrocephalus
News Source: Ophelia Keating. (November 10, 2026). MRI Scans Frequently Alter Programmable Shunt Valve Settings. Scienmag.
